Teva Pharmaceutical Industries Ltd (TEVA)
16.29
-0.01
(-0.06%)
USD |
NYSE |
May 17, 16:00
16.31
+0.02
(+0.12%)
Pre-Market: 20:00
Teva Pharmaceutical Industries Shareholders Equity (Quarterly): 7.278B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 7.278B |
December 31, 2023 | 7.506B |
September 30, 2023 | 6.929B |
June 30, 2023 | 7.052B |
March 31, 2023 | 7.86B |
December 31, 2022 | 7.804B |
September 30, 2022 | 8.767B |
June 30, 2022 | 9.037B |
March 31, 2022 | 9.344B |
December 31, 2021 | 10.28B |
September 30, 2021 | 10.47B |
June 30, 2021 | 10.32B |
March 31, 2021 | 10.00B |
December 31, 2020 | 10.03B |
September 30, 2020 | 9.593B |
June 30, 2020 | 13.85B |
March 31, 2020 | 13.53B |
December 31, 2019 | 13.97B |
September 30, 2019 | 13.79B |
June 30, 2019 | 14.12B |
March 31, 2019 | 14.73B |
December 31, 2018 | 14.71B |
September 30, 2018 | 17.73B |
June 30, 2018 | 17.94B |
March 31, 2018 | 18.62B |
Date | Value |
---|---|
December 31, 2017 | 17.36B |
September 30, 2017 | 28.67B |
June 30, 2017 | 27.99B |
March 31, 2017 | 34.02B |
December 31, 2016 | 33.34B |
September 30, 2016 | 35.13B |
June 30, 2016 | 30.15B |
March 31, 2016 | 30.44B |
December 31, 2015 | 29.77B |
September 30, 2015 | 22.74B |
June 30, 2015 | 23.04B |
March 31, 2015 | 22.64B |
December 31, 2014 | 23.31B |
September 30, 2014 | 23.63B |
June 30, 2014 | 23.54B |
March 31, 2014 | 22.97B |
December 31, 2013 | 22.56B |
September 30, 2013 | 22.31B |
June 30, 2013 | 21.52B |
March 31, 2013 | 22.71B |
December 31, 2012 | 22.77B |
September 30, 2012 | 22.93B |
June 30, 2012 | 22.75B |
March 31, 2012 | 23.05B |
December 31, 2011 | 22.20B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
6.929B
Minimum
Sep 2023
14.12B
Maximum
Jun 2019
10.08B
Average
9.796B
Median
Shareholders Equity (Quarterly) Benchmarks
Viatris Inc | 20.01B |
Alvotech | -932.49M |
AstraZeneca PLC | 37.44B |
GSK PLC | 17.47B |
Johnson & Johnson | 70.02B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 42.77B |
Total Liabilities (Quarterly) | 35.23B |
Debt to Equity Ratio | 2.699 |
Current Ratio | 0.8916 |
Net Debt Paydown Yield | 1.96% |